Skip to main content

Advertisement

Log in

Analyzing the dynamics of cell growth and protein production in mammalian cell fed-batch systems using logistic equations

  • Fermentation, Cell Culture and Bioengineering
  • Published:
Journal of Industrial Microbiology & Biotechnology

Abstract

The logistic modeling approach was used to describe experimental viable cell density (X) and product concentration (P) data from two industrial fed-batch mammalian cell culture processes with maximum product concentrations in the 3.0–9.4 g/l range. In both cases, experimental data were well described by the logistic equations and the resulting specific growth rate and protein productivity profiles provided useful insights into the process kinetics. Subsequently, sensitivity equations for both the X and P models were analyzed which helped characterize the influence of model parameters on X and P time courses. This was augmented by conventional sensitivity analyses where five values of each model parameter, 25% apart, were used to generate X and P time courses. Finally, results from sensitivity analysis were used to simulate X and P time courses that were reflective of typical early- and late-stage fed-batch cell culture processes. Different combinations of the logistic model parameters were used to arrive at the same final product concentration demonstrating the ability of the logistic approach to describe the multitude of process paths that result in the same final product concentration. Overall, the capability of the logistic equations to well describe X and P data from fed-batch cultures, coupled with their ability to simulate the multitude of paths leading up to the desired cell density and product concentration profiles, make them a useful tool during mammalian cell fed-batch process development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Adams CP, Brantner VV (2010) Spending on new drug development. Health Econ 19:130–141

    Article  PubMed  Google Scholar 

  2. Aggarwal S (2007) What’s fueling the biotech engine? Nat Biotechnol 25:1097–1104

    Article  PubMed  CAS  Google Scholar 

  3. Combs RG, Yu E, Roe S, Piatchek MB, Jones HL, Mott J, Kennard ML, Goosney DL, Monteith D (2011) Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells. Biotechnol Prog 27:201–208

    Article  PubMed  CAS  Google Scholar 

  4. DiMasi R, Hansen HA, Grabwoski H (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151–185

    Article  PubMed  Google Scholar 

  5. DiMasi R, Hansen R, Grabwoski H (2004) R&D costs and returns by therapeutic category. Drug Inf J 38:211–223

    Article  Google Scholar 

  6. Goudar CT (2009) Robust parameter estimation during logistic modeling of batch and fed-batch culture kinetics. Biotechnol Prog 25:801–806

    Article  PubMed  CAS  Google Scholar 

  7. Goudar CT, Biener R, Konstantinov KB, Piret JM (2009) Error propagation from prime variables into specific rates and metabolic fluxes for mammalian cells in perfusion culture. Biotechnol Prog 25:986–998

    Article  PubMed  CAS  Google Scholar 

  8. Goudar CT, Joeris K, Konstantinov K, Piret JM (2005) Logistic equations effectively model mammalian cell batch and fed-batch kinetics by logically constraining the fit. Biotechnol Prog 21:1109–1118

    Article  PubMed  CAS  Google Scholar 

  9. Huang Y-M, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog 26:1400–1410

    Article  PubMed  CAS  Google Scholar 

  10. Kelley BD (2007) Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog 23:995–1008

    PubMed  CAS  Google Scholar 

  11. Kelley BD (2009) Industrialization of mAB production technology. The bioprocessing industry at a crossroads. mAbs 1:441–452

    Article  Google Scholar 

  12. Kozlowski S, Swann P (2006) Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Deliv Rev 58:707–722

    Article  PubMed  CAS  Google Scholar 

  13. Krishnan M (2007) Monoclonal antibody gold rush. Curr Med Chem 14:1978–1987

    Article  Google Scholar 

  14. Reichert JM (2009) Global antibody trends. mAbs 1:86–87

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Insightful perspectives on the implications of final product concentration on process development and commercial manufacturing from Paul Wu, Harald Dinter, and Clive Wood, all of Bayer HealthCare, are appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chetan T. Goudar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goudar, C.T. Analyzing the dynamics of cell growth and protein production in mammalian cell fed-batch systems using logistic equations. J Ind Microbiol Biotechnol 39, 1061–1071 (2012). https://doi.org/10.1007/s10295-012-1107-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10295-012-1107-z

Keywords

Navigation